XERIS BIOPHARMA HOLDINGS, INC. (XERS) Return on equity 2020–2025
XERIS BIOPHARMA HOLDINGS, INC. (XERS) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
4.0%FY2025 · since FY2020: -270.0% → 4.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 4.0% | — |
| FY2022 | -209.5% | -80.6 pp |
| FY2021 | -128.9% | +141.1 pp |
| FY2020 | -270.0% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice